A national study of autogenous arteriovenous access use and patency in a contemporary hemodialysis population

Stoumpos, S., Traynor, J. P., Metcalfe, W., Kasthuri, R., Stevenson, K., Mark, P. B. , Kingsmore, D. B. and Thomson, P. C. (2019) A national study of autogenous arteriovenous access use and patency in a contemporary hemodialysis population. Journal of Vascular Surgery, 69(6), pp. 1889-1898. (doi:10.1016/j.jvs.2018.10.063) (PMID:30583903)

[img]
Preview
Text
171311.pdf - Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

719kB

Abstract

Objective: The predicted outcomes of autogenous arteriovenous (AV) hemodialysis access creation are predominantly based on historical data; however, both the hemodialysis population and clinical practices have changed significantly during the last decade. This study examined contemporary AV access clinical use and patencies. Methods: A multicenter observational cohort study was performed of all new AV accesses created in Scotland in 2015. The primary end point was efficacy assessed by successful AV access use for a minimum of 30 days and primary, primary assisted, and secondary patency at 1 year. Data obtained included all interventions to maintain or to restore patency. Predictors of patency loss including demographics, comorbid conditions, dialysis status, AV access location, duplex ultrasound surveillance, procedures, prior access, and antiplatelets were assessed. Kaplan-Meier and competing risks analyses were performed to estimate the probability of AV access failure. All patients were followed up for at least 1 year or had a censoring event. Results: A total of 582 AV accesses were created in 537 patients (mean age, 60 [standard deviation, 14] years; 60% men; 42% with diabetes) in nine adult renal centers. Mean follow-up was 11.8 (standard deviation, 7.6) months. By the end of the follow-up, 322 (55.3%) AV accesses were successfully used for dialysis. At 1 year, 48% (95% confidence interval [CI], 44-52) of AV accesses had primary patency, (95% CI, 63-71) had primary assisted patency, and 69% (95% CI, 65-73) had secondary patency. The leading cause of primary patency loss was primary failure (30%). An average of 0.48 intervention per patient-year was required to maintain patency. On multivariable analysis, patency was better for an upper arm than for a forearm AV access (1-year secondary patency of upper arm vs forearm AV accesses, 74% vs 58%). The cumulative hazard and incident functions for AV access failure were 31% (95% CI, 27-35) and 23% (95% CI, 20-27) at 1 year, respectively. Conclusions: Despite advances in recent years with preoperative vessel assessment and surveillance, patency rates have not improved, with primary failure remaining the major obstacle. Competing events should be taken into consideration; otherwise, biases may occur with overestimation of the probability of AV access failure.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Thomson, Dr Peter and Kingsmore, Mr David and Mark, Dr Patrick and Kasthuri, Dr Ram and Stoumpos, Dr Sokratis and Traynor, Dr Jamie
Authors: Stoumpos, S., Traynor, J. P., Metcalfe, W., Kasthuri, R., Stevenson, K., Mark, P. B., Kingsmore, D. B., and Thomson, P. C.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Journal of Vascular Surgery
Publisher:Elsevier
ISSN:0741-5214
ISSN (Online):1097-6809
Published Online:21 December 2018
First Published:First published in Journal of Vascular Surgery 69:1889-1898
Publisher Policy:Reproduced in accordance with the copyright policy of the publisher

University Staff: Request a correction | Enlighten Editors: Update this record